We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Exclusive 30-min webinar hosted by the Asia Regulatory Professionals Association showing you the clinical trial approval process, local ethics committee approval, import and export license requirements, pharmacovigilance requirements and tips to make it smoother and quicker.
Speakers: Natalya Eliseeva, Senior Regulatory Manager at OCT Clinical
Anna Yanaeva, Head of Business Development at OCT Clinical
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
